Do you love someone suffering from addiction, depression, and/or anxiety? Most of us do. These common conditions seem to have become even more prevalent during the pandemic and the political/social turmoil in recent years. Psilocybin-assisted counseling has proven to be effective in treating these conditions and other mental illnesses.
Washington state ranks 3rd in the nation for mental illness among adults (nearly 24% of the population), and a government survey ranked Washington 49th in the nation for psychiatric bed capacity. State payments to five private psychiatric hospitals nearly tripled over five years, totaling almost $67 million in 2018, and the near-term projection (including the construction of additional hospitals) totals $1 billion. With the mental healthcare crisis on the rise and a significant shortage of resources, our state and our nation clearly need more effective treatment options.
Our Mission
ADAPT (Addiction, Depression, Anxiety, Plant medicine Treatment) is a grassroots organization based in Washington state. Our mission is to advocate for the responsible use of psilocybin-assisted therapy and decriminalization of small amounts of entheogens. We believe that psilocybin, along with other entheogens, have the potential to revolutionize mental health care.
Why Psilocybin-Assisted Therapy Matters
- Effectiveness: Research indicates that psilocybin can significantly impact mental health conditions such as depression, anxiety, and PTSD, offering relief where conventional treatments have been inadequate.
- Comprehensive Care: Psilocybin-assisted therapy offers a comprehensive approach, addressing both the symptoms and the deeper emotional and psychological challenges. It helps individuals explore their consciousness, leading to insights that contribute to long-term healing.
- Breaking Stigma: By promoting psilocybin-assisted therapy, we seek to reduce the stigma surrounding mental health treatments, advocating for everyone to have access to safe and effective therapeutic options.
Read more about recent studies and clinical trials involving psilocybin in the news.